ライフサイエンスコーパス: testing

1 and (3) who lacked prior documented anti-HCV testing.

2 to those in controls, and resolved on repeat testing.

3 botanical drugs is mainly based on chemical testing.

4 ls for disease modeling and preclinical drug testing.

5 nt interactions after adjusting for multiple testing.

6 wice per year, coinciding with lung function testing.

7 frequent human immunodeficiency virus (HIV) testing.

8 ly significant after correction for multiple testing.

9 ves the speed and availability of diagnostic testing.

10 blood samples were obtained for HIV antibody testing.

11 rcine model was designed for the preclinical testing.

12 cologic vasodilators used for cardiac stress testing.

13 require large sample volumes and destructive testing.

14 del, establishing the rationale for clinical testing.

15 laboratory protocols for analysis and hazard testing.

16 al sugarcane varieties over 4 years of field testing.

17 ty are needed, for example, in point-of-care testing.

18 correction was used to account for multiple testing.

19 e and replace the use of animals in toxicity testing.

20 A total of 3301 youths underwent HIV testing.

21 T. pallidum were detected by serum antibody testing.

22 osis (68%), although 7 cases required repeat testing.

23 s permit conventional statistical hypothesis testing.

24 CMT1A fibroblasts as a platform for therapy testing.

25 obability, between cardiac CT and functional testing.

26 metallic compound/solder interface during EM testing.

27 mong recipients of donors with positive ZIKV testing.

28 SNPs was calculated to correct for multiple testing.

29 e PK profile, making it suitable for in vivo testing.

30 eatment high-risk human papillomavirus (HPV) testing.

31 ed-system-based antimicrobial susceptibility testing.

32 ave significant influence on future clinical testing.

33 The protocol includes testing 1) convergence of the model score, 2) whether mo

34 he dataset was split into training (90%) and testing (10%) sub-datasets.

35 602 patients randomly assigned to functional testing (33.4% versus 78.0%, and 0.9% versus 2.1%, respe

36 es a simple logistic regression approach for testing a priori hypotheses about variation in the odds

37 management, highlighting the role of genetic testing, a detailed pedigree, and refined clinical surve

38 ibly safe for early discharge without stress testing, a strategy that could have tremendous healthcar

39 s to expand access to reliable, high-quality testing across countries; (4) strengthening national lea

40 However, institutional testing activities in sub-Saharan Africa are currently l

41 patients most likely to benefit from stress testing after PCI.

42 morphologic selection of neoplastic tissue, testing algorithms, scoring methods, interpretation and

43 From 2-step testing, all glutamate dehydrogenase (GDH)-positive spec

44 ts not consenting to the intervention or HIV testing, although our conclusions were robust in sensiti

45 scalable approaches to promote uptake of HIV testing among youths at risk is critical.

46 s one or more positive results on skin prick testing and clinically relevant symptoms of rhinitis rel

47 or $10 if the participant presented for HIV testing and counselling at a local primary health-care c

48 The electrodes can be removed after testing and further modified or tested before being rein

49 sults on hepatitis B surface antigen (HBsAg) testing and had an undetectable HBV viral load, and 3 ha

50 al load, and 3 had negative results on HBsAg testing and had an undetectable HBV viral load.

51 The testing and implementation of novel yet unproven approac

52 We also provide methodology for hypothesis testing and interval estimation.

53 biomarker identification and drug-screening testing and led to the identification of the ERK inhibit

54 hroughout England would increase the cost of testing and monitoring CKD by approximately pound31 mill

55 in an internationally agreed protocol for CA testing and monitoring, and to promote its translation i

56 ) were skin test eligible; 43 (24%) received testing and none were allergic.

57 nique for successful gene expression profile testing and prognostic classification.

58 mutation carriers diagnosed through genetic testing and recruited through the HCHWA-D patient associ

59 ing, therapeutic target identification, drug testing and regeneration.

60 ted commonly cited rationale used to support testing and the generally poor evidence on which to base

61 AT), needle and syringe programs (NSPs), HIV testing and treatment (Test & Treat), and oral HIV pre-e

62 Multistage, stepwise HIV testing and treatment procedures can result in lost oppo

63 rd Hayes and colleagues' PopART study on HIV testing and treatment.

64 l illustrates many of the issues involved in testing and validating urban simulation models involving

65 Results from panel genetic testing and WGS were compared.

66 nderstanding of who should be considered for testing and when it should be performed to maximize clin

67 here are age-based requirements for periodic testing and/or retirement for many professions including

68 s are Sidak adjusted to account for multiple testing) and less likely to have normalising (p<0.008) a

69 ed in pregnancy or at least 4 weeks prior to testing, and a mother-to-child transmission (MTCT) rate

70 IMD(0), GES, water load testing, and symptoms were then compared in 177 patients

71 netic studies, and (iii) generating data for testing any multivariate method in genetic epidemiology.

72 a of human immunodeficiency virus (HIV) load testing are pivotal to limiting the threat of HIV drug r

73 Because the economics of water quality testing are poorly understood, the extent to which cost

74 emiology and argue for retaining statistical testing as an important part of the tool kit.

75 tatus, visual, cognitive, motor, and sensory testing, as well as qualitative and quantitative neuroim

76 ology and imaging, but a major impediment to testing ASD hypotheses is the lack of human cell models.

77 cation (ID) and antimicrobial susceptibility testing (AST) results for the most commonly identified o

78 frequency-matched healthy controls underwent testing at commensurate time points.

79 Guidelines for cancer genetic testing based on family history may miss clinically acti

80 alongside policy requirements for mandatory testing before treatment motivates exploration of noninv

81 Testing can be problematic, because the CLSI does not re

82 eeded to improve access to and uptake of HIV testing, care, and treatment, and management of non-comm

83 ad 198% higher odds of receiving no glaucoma testing compared with whites possessing commercial healt

84 the One4All group, 177 (76%) of 232 achieved testing completeness within 30 days versus 63 (26%) of 2

85 assessed for the primary outcome, which was testing completeness within 30 days, defined as completi

86 tional statistical comparisons without multi-testing correction can generate a large number of false

87 large number of false positives while multi-testing correction tremendously decreases the statistic

88 8967, was associated with BMI after multiple testing corrections (combined P = 2.20 x 10(-4)).

89 Meta-analyses were performed and multiple testing corrections were carried out using the Bonferron

90 om the literature when required, using trial testing costs and projecting future costs of treatment.

91 tients, 22.2% met BRCA1 and BRCA2 ( BRCA1/2) testing criteria and not LS criteria, and 5.1% met neith

92 riteria, and 5.1% met neither BRCA1/2 nor LS testing criteria.

93 he combination of serology and urine POC-CCA testing detected all 23 microscopy-positive study partic

94 ntify families who will benefit from genetic testing, determine the best strategy, and interpret resu

95 chocolate-based food matrix was optimized by testing different temperatures, extraction times, and th

96 ver Disease Symptom Index-2.0 (LDSI-2.0) for testing disease specific HRQoL and (4) the Center for Ad

97 We offered residents repeated rapid HIV testing during home-based visits every 6 months for abou

98 83.3 [13.5] years) underwent NASH FibroSure testing during MTX therapy and were eligible for correla

99 les attributed to DCM, comprehensive genetic testing encompasses ever-increasing gene panels.

100 d tomography angiography (CTA) or functional testing (exercise electrocardiography or nuclear stress

101 e (CAD) were randomly assigned to functional testing (exercise electrocardiography, nuclear stress, o

102 inition of familial PCA for clinical genetic testing, expanding understanding of genetic contribution

103 al entity that connects appropriate physical testing facilities, and other components needed for a te

104 th incident AF after correction for multiple testing (FDR < 0.05).

105 ervical/anal cytologic and cervical/anal HPV testing for 2 years.

106 ing sequential adjustment for covariates and testing for an age-sex interaction.

107 can continue without the need for concurrent testing for bacterial vaginosis or vaginal dysbiosis.

108 Purpose Genetic testing for breast cancer risk is evolving rapidly, with

109 to compare continuous variables, chi-square testing for categorical comparisons, and the generalized

110 testing for Zika virus as well as diagnostic testing for Dengue fever and West Nile virus.

111 Inadequate access to rapid testing for Ebola virus disease during the 2014-to-2016

112 Testing for Ebola virus was done by real-time PCR and fo

113 Testing for environmental similarity between native and

114 em, followed by breeding to homozygosity and testing for immune system phenotypes.

115 of all five LS genes and supports LS genetic testing for individuals with scores >/= 2.5%.

116 dence-based recommendations about diagnostic testing for latent tuberculosis infection, pulmonary tub

117 ecision prevention efforts, including: tumor testing for mismatch repair (MMR) deficiency in Lynch sy

118 We addressed this knowledge gap by testing for multi-decade trends in species richness in n

119 iority margin was 5 letters, and statistical testing for noninferiority was based on a 1-sided 97.5%

120 ssive PCA, exploring clinical use of genetic testing for PCA management, genetic testing of African A

121 atory approaches to operationalize molecular testing for predictive and prognostic molecular biomarke

122 Purpose Guidelines are limited for genetic testing for prostate cancer (PCA).

123 ngton disease), and thus was used in genetic testing for screening individuals at high risk.

124 e CT Angiography in Comparison to Functional Testing for Suspected Coronary Artery Disease) prospecti

125 Kaslow et al. also described baseline testing for the causative agent of AIDS, the human immun

126 eld with an increasing number of choices for testing for the practicing clinician to navigate.

127 Observations: The main value of testing for viruses in children who present with a respi

128 er IgM antibody or polymerase chain reaction testing for Zika virus as well as diagnostic testing for

129 ercise electrocardiography or nuclear stress testing) from 2009 to 2015.

130 The total time for antibiotic susceptibility testing, from loading of sample to diagnostic readout, i

131 ngpt provides both estimation and hypothesis testing functionalities for four common variants of thre

132 Behavioral testing (handling and open field), continuous video-elec

133 Quantitative microfluidic point-of-care testing has been translated into clinical applications t

134 Advances in MRI and serological and genetic testing have greatly increased accuracy in distinguishin

135 Because of statistical testing hierarchical rules, the 50-mug patch was not com

136 ially expressed miRNAs, spearman correlation testing highlighted correlation of hsa-miR-642a-3p, hsa-

137 f data from different trials and study sites testing HIV-1 clade C-specific products.IMPORTANCE HIV-1

138 The VWFA is a critical region for testing hypotheses about the nature of cortical organiza

139 In 20 of 41 participants, panel genetic testing identified variants classified as pathogenic, li

140 Performing the testing in a clinically focused tiered fashion would be

141 s uncovered via a virtual screen followed by testing in a fluorescence anisotropy assay.

142 f PD, and isradipine is currently undergoing testing in a phase III clinical trial in early PD.

143 agulation at the time of stroke but suggests testing in childhood is not indicated.

144 ure study of how to best incorporate genomic testing in clinical decision-making and subsequent treat

145 168 c.640_644del5 indicates the need for its testing in Finnish patients with RIDDLE syndrome symptom

146 ose using the rule of 3 to recommend genetic testing in France and countries with low to moderate inc

147 n testing including antimicrobial resistance testing in men with symptoms of NGU as well as in their

148 two-part process involving: (1) statistical testing in order to determine the number of the underlyi

149 Gene-based association testing in the gender-combined dataset revealed eight lo

150 the 22 oncology drugs with required genetic testing in their labels.

151 utility as a second triage step after hrHPV testing in women with minor cervical lesions.

152 linical suspicion and specialised laboratory testing, in addition to culture, histopathology, and ima

153 Statistical testing included analysis of variance, t tests, and perm

154 tic M. genitalium nucleic acid amplification testing including antimicrobial resistance testing in me

155 Future prospective testing, including additional dimensions of quality of l

156 eishmanial vaccines are currently undergoing testing, including genetically modified live-attenuated

157 Susceptibility testing indicated that mmpT5 mutations are associated wi

158 s are increasing despite availability of PCR testing, indicating the need for strategies to improve a

159 these patterns in diverse systems, rigorous testing, intensive time-series datasets and improved sto

160 isk stratification tool that merges troponin testing into a clinical risk model for evaluation emerge

161 The mean costs of subsequent testing, invasive procedures, and medications were highe

162 Genomic testing is a rapidly evolving field with an increasing n

163 When HEV testing is considered, it is important to test for other

164 uation based on null hypothesis significance testing is doomed to yield a low proportion of reproduci

165 index of suspicion combined with diagnostic testing is essential component of severe acute respirato

166 Cardiopulmonary exercise testing is feasible in children with DCM and is useful t

167 on of pretest probability assessment with DD testing is feasible, but the safety and efficiency of su

168 Limiting wasteful testing is important for patient safety.

169 l diagnosis difficult; therefore, laboratory testing is needed to confirm the diagnosis.

170 resource limited settings where nucleic acid testing is not practical or feasible.

171 lutionary constraints, and further empirical testing is required.

172 One of the goals of POC testing is the development of a chip-based, miniaturized

173 mize the power while addressing the multiple testing issue, we implement filters to remove data sets

174 Testing it on the toric code, it has higher threshold th

175 has the potential to be implemented in food testing laboratories worldwide.

176 Results from cardiac testing, laboratory workup, and imaging were negative fo

177 Both without and with confirmatory testing, LE was 26.2 years for HIV-infected infants and

178 n cities, over 20 countries, with the aim of testing leaf deposited particles as indicator of atmosph

179 Our analyses predicted novel compounds for testing, many with anti-inflammatory properties, providi

180 uch minimal-risk patients, for whom deferred testing may be considered.

181 he value framework of genetic evaluation and testing men at risk for PCA-a clinically heterogeneous d

182 We applied field-testing methodology by analysing all the consecutive inp

183 hat calls for the exploration of alternative testing methods to reduce the number of subjects, refine

184 INTERPRETATION: Genotypic resistance testing might not accurately predict NRTI activity in pr

185 ormance characteristics of different cardiac testing modalities.

186 On direct testing, mutants of some of these genes exhibited marked

187 Nucleic acid amplification testing (NAAT) is the preferred method to detect Chlamyd

188 in populations by nucleic acid amplification testing (NAAT), as they involve a less invasive collecti

189 were subjects with acute respiratory illness testing negative for influenza.

190 this valuable model has been widely used for testing novel therapeutic approaches.

191 We used data from nine testing occasions spanning 28 y in the Swedish Adoption/

192 We assessed if direct testing of 2-month sputa with MTBDRplus can predict 2-mo

193 genetic testing for PCA management, genetic testing of African American males, and addressing the va

194 tic, because the CLSI does not recommend the testing of all producers of ESBLs and also falsely negat

195 e oral fluid results should be confirmed via testing of blood samples.

196 lly informed model that enables simultaneous testing of different pathways to incident adolescent-ons

197 es its transformative potential for in vitro testing of drug efficacy towards prediction of in vivo o

198 and to move from exploratory analyses to the testing of evolutionary theory.

199 rm with fully integrated sensing for on-body testing of human sweat.

200 Antimicrobial susceptibility testing of isolates from 4793 domestic and 1070 travel-a

201 sensitive nucleic acid detection methods and testing of multiple specimens improve sensitivity, multi

202 min, which allowed for rapid prototyping and testing of new crystal mounting designs, with a resin co

203 harmaceutical research requires pre-clinical testing of new therapeutics using both in-vitro and in-v

204 tumors ex vivo, thereby enabling preclinical testing of novel drugs and helping stratify patients usi

205 mutation, and importantly, allow the future testing of novel therapeutic agents.

206 on in the study of biliary disorders and the testing of novel therapeutic agents.

207 By applying next-generation functional testing of primary patient-derived lymphoma cells using

208 Testing of rectal swabs directly using the Xpert Carba-R

209 al Overlap Model), a new method that enables testing of significant associations between multiple gen

210 garding this commercially available NAAT for testing of specimens after mailing.

211 e discuss the need for explicit experimental testing of the effects of encroachment on ecosystem serv

212 this divide, as it would allow for rigorous testing of the role that biotic interactions play in det

213 51B and LbCYP51B, with fungicide sensitivity testing of the transformants, suggests that both protein

214 Preclinical animal testing often fails to predict adverse outcomes arising

215 Source testing on Chinese residential coal combustion provides

216 is no scientific basis for doing so, as when testing only the null hypothesis; and 3) statistical rei

217 Patients with testing ordered for C. difficile were enrolled and assig

218 smetics industries for preservative efficacy testing (PET).

219 Point-of-care (POC) diagnostic testing platforms are a growing sector of the healthcare

220 f ketamine has immense prospective for field-testing platforms.

221 tential for the development of point-of-care testing (POCT) devices that can be applied in healthcare

222 Rapid point-of-care testing (POCT) for respiratory viruses might improve cli

223 fined by the presence of at least 2 adjacent testing points located within the same hemifield that sh

224 variations in both surveillance methods and testing policies.

225 ere is an emerging role for germline genetic testing potentially predicting sensitivity to platinum s

226 support groups, uncertain results on genomic testing predicted second opinion use.

227 mic data analysis, we propose a new multiple testing procedure, named Bon-EV, to control false discov

228 The simplicity of the automated testing procedures may make this test suitable for rapid

229 ead extraction, and defibrillation threshold testing procedures.

230 ad exposures from state-based food and candy testing programs provides an opportunity to identify and

231 For diagnostic ability testing purposes, we also examined as predictors phenoty

232 This study describes national testing rates and prevalence of HIV, HCV, and HBV among

233 ionnaire) and cardiac limitation on exercise testing (reduced peak oxygen consumption, 24+/-1.3 versu

234 We initially evaluated the assay by testing reference Leishmania isolates and comparing the

235 entially important differences were seen in: testing repertoire [10/44 (23%) lacked BSACI compliant n

236 f focusing on an individual patient, genetic testing requires consideration of the family as a unit.

237 o target activity data (e.g. animal toxicity testing results), the integrated cheminformatics algorit

238 of ordering of tests and turnaround time for testing results.

239 Autonomic nervous system testing revealed no abnormalities in heart rate and bloo

240 ts should be used in a manner similar to the testing/screening method for neural tube defects and com

241 This work provides a method for testing selective theories of language change against a

242 e-STI testing services require long-term monitoring and evalua

243 that we validated in 18 additional patients (testing set, 112 CTC samples) and in six SCLC patient-de

244 aluated retrospectively using an independent testing set.

245 Genetic testing should be advocated in young patients with ACS a

246 Genetic testing should be considered in individuals with cardiom

247 r, eczema, food allergy, positive skin prick testing (SPT), or elevated allergen-specific serum/plasm

248 In contrast to Hess screen testing, strabismus video goggle measurements were even

249 on and automated-system-based susceptibility testing straight from the light scatter suspension might

250 nd predictive methodologies into alternative testing strategies (ATS).

251 A clinically directed tiered testing strategy can increase sensitivity and improve st

252 ll type I error rate at 0.05, a hierarchical testing strategy was used for the second primary end poi

253 undiagnosed diabetes by using a confirmatory testing strategy, in line with clinical practice guideli

254 Little is known about the impact of another testing strategy, routine universal anorectal screening

255 Subsequent in vivo testing supported this hypothesis.

256 on assessments with cardiopulmonary exercise testing, symptom questionnaires, and dobutamine stress e

257 A carefully designed tensile testing technique for the MWCNTs is developed, which all

258 Furthermore, by testing the directionality of these links through statis

259 a novel analytical framework for mapping and testing the distribution of these QTL.

260 cycles.Antihydrogen studies are important in testing the fundamental principles of physics but produc

261 ght to reconcile these competing accounts by testing the hypothesis that extensive behavioral trainin

262 Testing the impact of the individual redesigned segments

263 We consider six methods for testing the Lasso coefficients: two permutation (Lasso-A

264 ted to assess the accuracy of penicillin MIC testing, the penicillin disk diffusion test, and three b

265 Among subjects with paired testing, the percent predicted maximum oxygen uptake dec

266 After correction for multiple testing, three of the 78 microRNAs remained significant.

267 We then performed repeat behavioral testing to identify which brain areas show cellular adap

268 from primarily relying on traditional animal testing to incorporating advances in biotechnology and p

269 eristics, including receipt of perinatal HIV testing, treatment, and prophylaxis.

270 n this study support a single breakpoint for testing trimethoprim-sulfamethoxazole and/or trimethopri

271 en less than 1 in 200 patients deferred from testing truly had an HSV CNS infection.

272 d and sexually active consented to HIV-1 RNA testing twice a week and biological sampling and risk as

273 ; we simulated guideline-concordant rates of testing uptake, result return, and antiretroviral therap

274 work, we introduce a framework for creating, testing, versioning and archiving portable applications

275 age of patients when they underwent genetic testing was 45+/-17, and they were followed for a median

276 The yield of cardiomyopathy gene panel testing was 9%.

277 , VO on, both on, and both off (the order of testing was chosen by a computer-generated random sequen

278 Non-HLA antibody testing was included in the posttransplant evaluation fo

279 Risk-stratified testing was less costly than MR cholangiopancreatography

280 fficult to distinguish clinically, and rapid testing was not available in many Ebola Treatment Units

281 Molecular testing was performed for respiratory viruses in nasopha

282 Testing was performed on samples from 683 subjects (306

283 Conditional and gene-based testing was undertaken, and variants were investigated w

284 (FDA) and required pharmacogenomic biomarker testing, we describe 1) the use of enrichment (biomarker

285 For the hypothesis testing, we proposed a novel sequential likelihood ratio

286 Using causal inference testing, we searched causal variants across eight cardio

287 giography and revascularization after stress testing were ascertained.

288 y and had results of oral and penile HPV DNA testing were examined.

289 n previous work, we address this question by testing whether a preconditioned cue will support condit

290 Although a definitive trial testing whether correcting metabolic acidosis improves c

291 ery plaque, and ongoing clinical studies are testing whether there is an association between (18)F-Na

292 ory has led to increased reliance on genetic testing, which, in turn, has raised new diagnostic chall

293 roscopic examination, and rapid nonmolecular testing, while approximately 60% performed culture inter

294 h stable chest pain referred for noninvasive testing will have normal coronary arteries and no long-t

295 er who underwent initial noninvasive cardiac testing with either coronary computed tomography angiogr

296 age-specific approaches to confidential HIV testing with linkage to HIV services.

297 olecularly confirmed (ABCA4) STGD1 underwent testing with the Nidek MP-1 microperimeter as part of th

298 seven with VOS after correction for multiple testing, with one novel locus for BUA at FAM167A (8p23.1

299 -cost alternative to conventional laboratory testing, with the goal of improving accessibility to med

300 Genetic testing within the B-other group revealed the presence o